Besides interesting data on novel treatment options for melanoma patients, the 19th European Association of Dermato-Oncology (EADO) congress featured several sessions on non-melanoma skin cancer. Below, we give an overview of recent advances in cutaneous squamous cell carcinoma (CSCC), basal cell carcinoma (BCC) and Merkel Cell Carcinoma (MCC), as well as some promising new treatment strategies and combinations.
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
